Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. (Q51625833)
Jump to navigation
Jump to search
scientific article published on 9 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. |
scientific article published on 9 July 2009 |
Statements
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. (English)
1 reference
N Putzki
1 reference
O Yaldizli
1 reference
M Mäurer
1 reference
S Cursiefen
1 reference
S Kuckert
1 reference
C Klawe
1 reference
M Maschke
1 reference
B Tettenborn
1 reference
V Limmroth
1 reference
9 July 2009
1 reference
17
1 reference
1
1 reference
31-37
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference